Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme, a mouth spray that prevents common cold and reduces the duration of illness. It also provides enzyme formulations. The company sells its products under the ViruProtect, STADAProtect, and Zerinol brand names. Enzymatica AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.22647799539796712 | N/A |
Market Cap | $37.20M | N/A |
Shares Outstanding | 164.26M | N/A |
Employees | 19.00 | N/A |